Kanada - angličtina - Health Canada

teva canada limited - liothyronine (liothyronine sodium) - tablet - 5mcg - liothyronine (liothyronine sodium) 5mcg - thyroid agents

Kanada - angličtina - Health Canada

teva canada limited - liothyronine (liothyronine sodium) - tablet - 25mcg - liothyronine (liothyronine sodium) 25mcg - thyroid agents

Spojené státy - angličtina - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 10 ug in 1 ml - liothyronine sodium injection (t 3 ) is indicated in the treatment of myxedema coma/precoma. liothyronine sodium injection (t 3 ) can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency or untreated thyrotoxicosis. thyroid hormone preparations are also generally contraindicated in patients with hypersensitivity to any of the active or extraneous constituents of these preparations; however, there is no well-documented evidence in the literature of true allergic or idiosyncratic reactions to thyroid hormone. concomitant use of liothyronine sodium injection (t 3 ) and artificial rewarming of patients is contraindicated. (see precautions.)

Spojené státy - angličtina - NLM (National Library of Medicine)

sigmapharm laboratories, llc - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 5 ug - liothyronine sodium tablets, usp are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. liothyronine sodium tablets, usp are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. liothyronine sodium tablets, usp are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. limitations of use - liothyronine sodium tablets, usp are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium tablets, usp may induce hyperthyroidism [see warnings and precautions (5.4)]. - liothyronine sodium tablets, usp are not indicated for treatment of hypothyroidism during the recovery phase of s

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - liothyronine sodium, quantity: 20 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; acacia; sodium chloride; magnesium stearate - indications as at 01 jan 1991 : tertroxin is indicated in the treatment of : coma due to myxoedema; management of severe thyroid deficiency; hypothyroid states arising in treatment of thyrotoxicosis. tertroxin may be preferred for treating severe and acute hypothyroid states because of its rapid and more potent effect but thyroxine sodium is normally the drug of choice for routine replacement therapy. tertroxin can also be used therapeutically in the treatment of thyrotoxicosis as an adjunct to carbimazole in order to prevent sub-clinical hypothyroidism developing during treatment.

Spojené státy - angličtina - NLM (National Library of Medicine)

bryant ranch prepack - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 25 ug - thyroid hormone drugs are indicated: - as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema and ordinary hypothyroidism in patients of any age (pediatric patients, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary) or tertiary (hypothalamic) hypothyroidism (see warnings ). - as pituitary thyroid-stimulating hormone (tsh) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (hashimoto's) and multinodular goiter. - as diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland

Spojené státy - angličtina - NLM (National Library of Medicine)

paddock laboratories, llc - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 5 ug - thyroid hormone drugs are indicated: liothyronine sodium tablets, usp can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis and apparent hypersensitivity to any of their active or extraneous constituents. there is no well-documented evidence from the literature, however, of true allergic or idiosyncratic reactions to thyroid hormone.

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - liothyronine sodium - oral tablet - 20microgram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - liothyronine sodium - oral tablet - 20microgram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - liothyronine sodium - oral tablet - 20microgram